Related Experiment Video
Updated: Feb 18, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long noncoding RNA LINC00961 inhibits cell invasion and metastasis in human non-small cell lung cancer
Bin Jiang1, Jing Liu2, Yu-Hong Zhang3
1Department of Urology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, People's Republic of China.
Abstract:
Long noncoding RNAs (LncRNAs) expression has been found to be misregulated in multiple human cancers, and a growing number of studies have revealed that lncRNAs can function as important oncogenes or tumor suppressors. In this study, we identified a lncRNA-LINC00961, which was significantly down-regulated in human non-small cell lung cancer tissues. Decreased LINC00961 was associated with NSCLC patients advanced clinical stage, lymph node metastasis, and shorter survival time. Further experiments demonstrated that LSD1 could directly bind to LINC00961 promoter regions and epigenetically repress its transcription in NSCLC cells. Moreover, MTT assays showed that LINC00961 had no influence on NSCLC cell proliferation. Ectopic overexpression of LINC00961 inhibits NSCLC cell migration, invasion in vitro and metastasis in vivo. Finally, qRT-PCR and western blot assays revealed that LINC00961 could act as a tumor suppressor partially via affecting β-catenin expression. Collectively, decreased LINC00961 might play a key role in NSCLC progression, and may serve as a novel prognostic marker in human NSCLC.
Insights
The long noncoding RNA LINC00961 is downregulated in non-small cell lung cancer (NSCLC). Lower LINC00961 levels correlate with advanced NSCLC and poor survival, suggesting it acts as a tumor suppressor.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long noncoding RNAs (LncRNAs) are increasingly recognized for their roles in cancer, acting as oncogenes or tumor suppressors.
- Dysregulation of lncRNA expression is a hallmark of various human malignancies, including lung cancer.
Purpose of the Study:
- To investigate the role of the lncRNA LINC00961 in non-small cell lung cancer (NSCLC).
- To determine the clinical significance and functional mechanisms of LINC00961 in NSCLC progression.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and Western blot analysis to assess LINC00961 and β-catenin expression.
- Analysis of the association between LINC00961 expression and clinical parameters in NSCLC patients.
- In vitro and in vivo experiments to evaluate the effect of LINC00961 on NSCLC cell migration, invasion, and metastasis.
- Chromatin immunoprecipitation (ChIP) assays to investigate the interaction between LSD1 and the LINC00961 promoter.
Main Results:
- LINC00961 was significantly downregulated in NSCLC tissues and associated with advanced stage, lymph node metastasis, and shorter survival.
- LSD1 epigenetically repressed LINC00961 transcription in NSCLC cells.
- Overexpression of LINC00961 inhibited NSCLC cell migration, invasion, and metastasis.
- LINC00961 suppressed NSCLC progression partly by affecting β-catenin expression.
Conclusions:
- Decreased LINC00961 expression is implicated in NSCLC progression.
- LINC00961 functions as a tumor suppressor in NSCLC.
- LINC00961 may serve as a potential prognostic biomarker for human NSCLC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons
Experimental RNAi
